Oncology

News

Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi

Regulatory T-cell scientist trio wins Nobel Prize

The Nobel Prize in Physiology or Medicine goes to three scientists for their work on regulatory T-cells, spawning hundreds of trials of new therapies.

Oncology

Chemicals in test tubes on a rack in a lab

Advancing radiopharmaceutical development: Preclinical preci...

Radiopharmaceutical development must move beyond fixed paradigms toward patient-specific, data-driven optimisation.

News

Dr Ken Macnamara, Trogenix's chief executive

UK's Trogenix raises £70m for cancer immunotherapy platform

Edinburgh-based Trogenix has raised £70m to fund clinical trials of its triple-acting immunotherapies for brain and colorectal cancers.

News

Delayed TNBC readout for Datroway delivers survival benefit

AstraZeneca and Daiichi Sankyo's Datroway comes good in the delayed TROPION-Breast02 trial as a frontline triple-negative breast cancer treatment.

News

Jazz, Roche combo cleared by FDA for lung cancer

Can FDA approval of Jazz Pharma's Zepzelca in a combination regimen for extensive-stage small cell lung cancer return sales of the drug to growth?

News

Umoja's in vivo cell therapy fast-tracked by FDA

A pioneer of in vivo cell therapy, Umoja has cleared another regulatory milestone by getting fast-track status for its lead blood cancer programme.

Regulatory T-cell scientist trio wins Nobel Prize

Advancing radiopharmaceutical development: Preclinical preci...

UK's Trogenix raises £70m for cancer immunotherapy platform

Delayed TNBC readout for Datroway delivers survival benefit

Jazz, Roche combo cleared by FDA for lung cancer

Umoja's in vivo cell therapy fast-tracked by FDA

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks